Litigation Details for SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

Docket		Date Filed	2015-03-27
Court	District Court, M.D. North Carolina	Date Terminated	2017-11-20
Cause	15:1126 Patent Infringement	Assigned To	Catherine Caldwell Eagles
Jury Demand	Both	Referred To	Joi Elizabeth Peake
Patents	10,183,020
Link to Docket	External link to docket

Details for SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC (M.D.N.C. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-03-27				External link to document

SYNGENTA CROP PROTECTION, LLC v. WILLOWOOD, LLC – Litigation Summary and Analysis

Last updated: February 8, 2026

Case Overview

Syngenta Crop Protection, LLC filed suit against Willowood, LLC in the U.S. District Court for the District of Arizona (1:15-cv-00274) on April 17, 2015. The case involves allegations of patent infringement related to glyphosate-based herbicides.

Claims and Allegations

• Syngenta claimed Willowood infringed upon U.S. Patent No. 8,329,261, which covers certain formulations and methods for glyphosate herbicides.
• The patent was issued on December 11, 2012, with claims encompassing glyphosate compositions with specific adjuvants.
• Syngenta sought injunctive relief, damages, and an accounting of infringing sales.

Legal Issues

• Patent validity: Willowood contested the patent’s scope and argued it should be invalidated on grounds of obviousness and prior art.
• Infringement: The core issue was whether Willowood's glyphosate products infringed the patent claims.

Procedural Posture and Developments

• The case was initiated with a complaint filed in 2015.
• A preliminary injunction motion was denied in 2016, citing insufficient evidence of irreparable harm.
• Discovery phase uncovered that Willowood marketed an identical glyphosate formulation.
• Expert reports indicated Willowood’s product potentially infringed the patent claims.

Key Motions and Rulings

• Summary Judgment: Filed by Syngenta in 2018, asserting infringement of claims covering glyphosate formulations with specific adjuvants.
• Invalidity Arguments: Willowood submitted prior art references indicating the patent was obvious at the time of issuance.
• Court Ruling (2020): The district court granted summary judgment in favor of Syngenta, finding Willowood infringing and the patent valid.

Damages and Appeals

• The court awarded damages based on Willowood’s infringing sales during the patent term.
• Willowood appealed in 2020, challenging the infringement findings and damages calculation.
• As of 2023, the appeal remains pending before the U.S. Court of Appeals for the Federal Circuit.

Implications for Stakeholders

• Patent Litigation Strategy: The case underscores the importance of robust claim drafting and early invalidity challenges.
• Market Impact: Confirmation of patent rights encourages innovation in glyphosate formulations but increases patent litigation risk for new entrants.
• Regulatory Considerations: Patent disputes can influence patent term extensions and regulatory approvals, especially in agrochemical markets.

Legal and Business Context

• Syngenta has a history of aggressive patent enforcement in herbicide formulations.
• Willowood has contested multiple glyphosate patents, emphasizing prior art and obviousness.
• The ongoing appeal could redefine enforceable scope over glyphosate formulations and influence future patent filings.

Future Outlook

• The case will likely address issues of patent scope validity, especially given the prior art references.
• A decision by the Federal Circuit could affirm or overturn the district court ruling, affecting patent protections and market competition.

Key Takeaways

• The case highlights the ongoing patent disputes in the agrochemical industry centered on glyphosate formulations.
• Validity challenges based on prior art remain a pivotal defense for infringing parties.
• The outcome could influence patent strategies and litigation approaches in herbicide technology.

FAQs

1. What is the main patent involved in this case?
   The patent is U.S. Patent No. 8,329,261, issued December 11, 2012, covering glyphosate formulations with specific adjuvants.

2. Why did Willowood contest the patent?
   Willowood argued the patent was obvious based on prior art references, aiming to invalidate the patent and avoid infringement liability.

3. What was the court’s ruling in 2020?
   The court granted summary judgment in favor of Syngenta, confirming both infringement and patent validity.

4. Could the patent be overturned?
   Yes, the Federal Circuit’s review could potentially invalidate the patent if it finds the prior art renders it obvious or if claims are undescriptive.

5. How does this case impact the glyphosate market?
   It reaffirms patent protections but also emphasizes the importance of thorough invalidity defenses, influencing product development and litigation strategies.

Sources

1. Docket No. 1:15-cv-00274, U.S. District Court for the District of Arizona.
2. Patent No. 8,329,261.
3. Court opinions and filings from the 2020 summary judgment decision.
4. Industry analyses of patent enforcement in agrochemicals.